Bioluminux Clinical Research Illinois, based in Naperville, serves a diverse adult and older adult population, ideal for a wide range of clinical studies. The community’s demographics show a substantial proportion of adults, with 24.8% under 65 and 13.9% over 65, providing a solid base for studies in adult health and aging-related research.
The population is 63.6% White (Non-Hispanic), 21.0% Asian, 4.6% Black or African American, 6.0% identifying as two or more races, and 6.9% Hispanic or Latino. This diversity allows us to conduct trials that encompass a variety of genetic backgrounds and cultural perspectives, which is valuable in producing more representative study results. Additionally, the median household income of $143,754 and per capita income of $67,706, with only 4.3% below the poverty line, indicate high healthcare access and strong potential for study engagement.
Educationally, 97.5% of residents aged 25 and older have completed high school, with 70.9% holding a bachelor’s degree or higher. This high level of educational attainment supports participants’ understanding of clinical trial requirements and informed consent. Furthermore, with 21.9% of the population being foreign-born, we are equipped to implement culturally sensitive practices in our research.
These demographics enable Bioluminux Clinical Research Illinois to conduct comprehensive and inclusive studies tailored to adults and older adults, contributing valuable insights to healthcare.